Practical application. Population A ELISA test is applied to a million people where 1% are infected with HIV. Of the million people, 10,000 would be infected.

Slides:



Advertisements
Similar presentations
Laboratory Training for Field Epidemiologists Sensitivity and specificity Predictive values positive and negative Interpretation of results Sep 2007.
Advertisements

Sensitivity, Specificity and ROC Curve Analysis.
What Happens to the Performance of a Diagnostic Test when the Disease Prevalence and the Cut-Point Change? Pathological scores Healthy scores Healthy population.
TUTORIAL SCREENING Dr. Salwa Tayel, Dr. A. Almazam, Dr Afzal Mahmood
SCREENING FOR DISEASE Nigel Paneth. THREE KEY MEASURES OF VALIDITY 1.SENSITIVITY 2.SPECIFICITY 3.PREDICTIVE VALUE.
Is Nucleic Acid Testing for Organ Donors the ‘Right’ Choice? Reference: Humara A, Morrisb M, Blumbergc R, et al. Nucleic acid testing (NAT) of organ donors:
Statistical Fridays J C Horrow, MD, MSSTAT
Baye’s Rule and Medical Screening Tests. Baye’s Rule Baye’s Rule is used in medicine and epidemiology to calculate the probability that an individual.
Screening for HBsAg and Anti-HBc in North American Blood Donors John Saldanha, Roche Molecular Systems SoGAT XXI, May, 2009, Brussels, Belgium.
Principles of Epidemiology Lecture 12 Dona Schneider, PhD, MPH, FACE
HIV Testing CDC power point edited by M. Myers
Prevalence and risk relationships of tattoo, acupuncture and skin/body piercing histories among American Red Cross blood donors Sharyn Orton, MSPH, PhD.
(Medical) Diagnostic Testing. The situation Patient presents with symptoms, and is suspected of having some disease. Patient either has the disease or.
What is Screening? Basic Public Health Concepts Sheila West, Ph.D. El Maghraby Professor of Ophthalmology Wilmer Eye Institute Johns Hopkins University.
Background Donor Suitability Consultation was held in Atlanta June 26-27, 2001 To review and consult on the 1994 CDC Guidelines for Preventing Transmission.
Random Thoughts 2012 (COMP 066) Jan-Michael Frahm Jared Heinly.
21 August 2015 Samreen Ijaz Virus Reference Department Health Protection Agency Indigenous HEV infection in the UK: a hazard for blood donation?
Pooled Source Plasma NAT for HIV-1 An Update from the Bayer HIV-1 IND Study Barbara Masecar Bayer Corporation Raleigh, NC Blood Products Advisory Committee.
Epidemiology made easy -or- “Lies, damn lies, and statistics”
Statistics in Screening/Diagnosis
WHY YOU NEED TO CREATE AN AWARENESS FOR AIDS Click to Continue to Next Page.
DEB BYNUM, MD AUGUST 2010 Evidence Based Medicine: Review of the basics.
Homework 12 Welcome to the HIV cost calculator A tool to assist in answering the question "Why not test everyone?"
HSS4303B Intro to Epidemiology Feb 4, 2010 – Screening Tests.
Basic statistics 11/09/13.
Interpreting numbers – more tricky bits ScotPHO training course March 2011 Dr Gerry McCartney Head of Public Health Observatory Division NHS Health Scotland.
Statistics for Health Care Biostatistics. Phases of a Full Clinical Trial Phase I – the trial takes place after the development of a therapy and is designed.
Statistics for nMRCGP Jo Kirkcaldy. Curriculum Condensed Knowledge Incidence and prevalence Specificity and sensitivity Positive and negative predictive.
SCREENING Asst. Prof. Sumattna Glangkarn RN, MSc. (Epidemiology), PhD (Nursing studies)
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
When to Confirm a Positive NAAT An additional test should be considered after a positive screening test if a false-positive screening test would result.
Statistics. Statistics = everything you need to know, but continually want to forget!!!!
Aristotelis Tsiakalos, MD, PhD. Prevalence of HIV infection in Greece until 2011: 7.4/ population.
YEAR 13 STATISTICS & MODELLING WORKSHOP DEPARTMENT OF STATISTICS House Sales What proportion of the houses that sold for over $600,000 were on the market.
Likelihood 2005/5/22. Likelihood  probability I am likelihood I am probability.
Screening Puja Myles
SCREENING Dr. Aliya Hisam Community Medicine Dept. Army Medical College, RWP.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
HSS4303B – Intro to Epidemiology Feb 8, Agreement.
Positive Predictive Value and Negative Predictive Value
Predictive values prevalence CK and acute myocardial infarction –sensitivity 70% –specificity 80% –prevalence - 40% –prevalence - 20% –PPV and NPV.
To enhance students ability to interpret data in charts and graphs To discuss basic concepts in epidemiology and science.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Independent events Two events are independent if knowing that one event is true or has happened does not change the probability of the other event. “male”
Timothy Wiemken, PhD MPH Assistant Professor Division of Infectious Diseases Diagnostic Tests.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
دکتر حمیدرضا صابری
Diagnostic studies Adrian Boyle.
Performance of a diagnostic test Tunisia, 31 Oct 2014
…it’s really interesting
DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M
Principles of Epidemiology E
Introduction Results Conclusions Methods
Class session 7 Screening, validity, reliability
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
How do we delay disease progress once it has started?
How do we judge efficacy of a screening test?
What is Screening? Basic Public Health Concepts Sheila West, Ph.D.
دكتر محسن ميرزائي MD , MPH
Refining Probability Test Informations Vahid Ashoorion MD. ,MSc,
Dr. Hannah Jordan Lecturer in Public Health ScHARR
House Sales What proportion of the houses that sold for over $600,000 were on the market for less than 30 days? Days on the market Less than 30 days 30.
Figure 1. Table for calculating the accuracy of a diagnostic test.
Patricia Butterfield & Naomi Chaytor October 18th, 2017
An Assessment of the Screening Performance of a Single-Item Measure of Depression From the Edmonton Symptom Assessment Scale Among Chronically Ill Hospitalized.
Positive predictive value of screening tests
Chapter 2, Unit E Screening Tests.
Clinical Effectiveness: sensitivity, specificity and PPV
Presentation transcript:

Practical application

Population A ELISA test is applied to a million people where 1% are infected with HIV. Of the million people, 10,000 would be infected with HIV among whom the test detected 9,990 to be positive. Of the 1 million people in this population, 990,000 are not infected, among whom the test had detected 990 individuals be positive by the ELISA. Calculate the following: Sensitivity and specificity Positive Predictive Value Negative Predictive Value

Sensitivity = a/(a+c)= 9990/( )= 99.9% Specificity= b/(b+d)= 989,000/( ,010)= 99.9% ELISA testHIV infectedNot infectedTotal Positive Negative10989, ,0001,000,000

Positive Predictive Value= a/(a+b) = 9990/( ) =91% Negative Predictive Value= d/(c+d) =989,010/(10+989,010) = 99.9%

The effects of prevalence on the predictive value of test results in two different populations. Population B Blood donors have already been screened for HIV risk factors before they are allowed to donate blood, so that the HIV sero-prevalence in this population is closer to 0.1% instead of 1%. For every 1,000,000 blood donors, 1,000 are HIV positive.

Sensitivity= 99.9% Specificity= 99.9% PPV= a/(a+b)=50% NPV= d/(c+d)=99.999% ELISAHIV infectedNot infectedTotal + ve990 1,998 - ve1998,001998,002 Total ,

With a sensitivity of 99.9%, the ELISA would pick up 999 of those thousand, but would fail to pick up one HIV sero-positive individual. Of the 999,000 uninfected individuals, the test would label 998,001 individuals assero- negative (true negatives). The ELISA would, however, falsely label 999 individuals as sero- positive (false-positives). Testing the blood donor pool results in as many false positive as true positive results.

Population C The second population consists of former IV drug users attending drug rehabilitation units, with a prevalence of 10%. For a million of these individuals, 100,000 would be HIV- infected and 900,000 would be HIV negative.

Sensitivity= 99.9% Specificity= 99.9% PPV=a/(a+b)=99% NPP= d/(c+d)= ELISAHIV infectedNot infectedTotal + ve999, ,800 - ve ,100899,200 Total100,000900,

The HIV ELISA would yield 99,900 true positives and 100 false negatives. Of the 900,000 HIV negative individuals, the ELISA will find 899,100 to be negative but falsely label 900 as positive.

Summary of example The sensitivity and specificity of the test has not changed. It is just that the predictive value of the test has changed depending on the population being tested.

The PPV is how many of the test- positives truly have the disease. In Pop. A 1% sero-positive rate, the ELISA has a PPV of 0.91 (91%). In blood donor with a 0.1% sero- prevalence, the PPV is only 0.5 (50%) In the high- prevalence population of intravenous drug users, the PPV is 0.99 (99%).

Although the sensitivity of the ELISA does not change between populations, the PPV changes drastically from only half the people that tested positive being truly positive in a low- incidence population to 99% of the people testing positive being truly positive in the high- prevalence population. The NPV of the ELISA also changes depending on the prevalence of the disease.

False positive results produced by high sensitivity of the screening test can easily be excluded by a confirmatory test with high specificity. Information on the possibility of false positive results and subsequent action should be provided to individuals prior to being screened (see informed consent).